Trial Outcomes & Findings for Transcranial Direct Current Stimulation for Chronic Low Back Pain (NCT NCT02768129)
NCT ID: NCT02768129
Last Updated: 2019-08-20
Results Overview
Subscale C of the West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) is a validated measure of chronic pain's effects on functioning. Ranging from 0-108, higher scores indicate more activity (better outcome).
COMPLETED
NA
30 participants
8 weeks total
2019-08-20
Participant Flow
Of the 30 participants that were consented, 9 participants were ineligible, withdrew, or were lost to contact before commencing tDCS.
Participant milestones
| Measure |
Sham tDCS
10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham
|
Active tDCS
10 sessions active transcranial direct current stimulation (tDCS)
transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins
|
|---|---|---|
|
Overall Study
STARTED
|
11
|
10
|
|
Overall Study
COMPLETED
|
11
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Transcranial Direct Current Stimulation for Chronic Low Back Pain
Baseline characteristics by cohort
| Measure |
Active tDCS
n=10 Participants
10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: active : 2 mA, 20 mins
|
Sham tDCS
n=11 Participants
10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham
|
Total
n=21 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
65.7 years
STANDARD_DEVIATION 8.8 • n=93 Participants
|
60.7 years
STANDARD_DEVIATION 11.8 • n=4 Participants
|
63.1 years
STANDARD_DEVIATION 10.5 • n=27 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=93 Participants
|
2 Participants
n=4 Participants
|
3 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=93 Participants
|
9 Participants
n=4 Participants
|
18 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
White
|
7 Participants
n=93 Participants
|
7 Participants
n=4 Participants
|
14 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
0 Participants
n=93 Participants
|
1 Participants
n=4 Participants
|
1 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Hispanic or Latino
|
1 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Asian
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or other Pacific Islander
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Other
|
2 Participants
n=93 Participants
|
3 Participants
n=4 Participants
|
5 Participants
n=27 Participants
|
|
Years of Education
|
14.0 years
STANDARD_DEVIATION 2.6 • n=93 Participants
|
14.7 years
STANDARD_DEVIATION 2.6 • n=4 Participants
|
14.4 years
STANDARD_DEVIATION 2.7 • n=27 Participants
|
PRIMARY outcome
Timeframe: 8 weeks totalSubscale C of the West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) is a validated measure of chronic pain's effects on functioning. Ranging from 0-108, higher scores indicate more activity (better outcome).
Outcome measures
| Measure |
Sham tDCS
n=11 Participants
10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham
|
Active tDCS
n=10 Participants
10 sessions active transcranial direct current stimulation (tDCS)
transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins
|
|---|---|---|
|
West Haven-Yale Multidimensional Pain Inventory (General Activity Subscale) Rating
|
35.3 score on a scale
Standard Deviation 17.7
|
48.4 score on a scale
Standard Deviation 21.2
|
PRIMARY outcome
Timeframe: 8 weeks totalThe Pain Anxiety Symptom Scale (PASS-20) is a validated measure of pain-related avoidance and fear. Total score ranges 0-100. Higher scores indicate greater pain anxiety.
Outcome measures
| Measure |
Sham tDCS
n=11 Participants
10 sessions sham transcranial direct current stimulation (tDCS)
sham transcranial direct current stimulation: sham
|
Active tDCS
n=10 Participants
10 sessions active transcranial direct current stimulation (tDCS)
transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins
|
|---|---|---|
|
Pain Anxiety Symptom Scale Rating
|
26.4 score on a scale
Standard Deviation 22.0
|
26.3 score on a scale
Standard Deviation 23.6
|
Adverse Events
Sham tDCS
Active tDCS
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place